Trial to Assess Chelation Therapy

Principal Investigator Name:		Pamela Ouyang, MBBS

Study Coordinator Name:		Melanie Herr, RN

Contact Phone:		(410) 550 - HART (4278) Study Coordinator

Contact E-mail:		mherr@jhmi.edu Study Coordinator

Study Short Title:		TACT Study

Study Long Title:		Trial To Assess Chelation Therapy

IRB Number:		HBV 03-06-19-01

Funding Source:		National Institutes of Health

Summary of Trial:		Volunteers are needed for a CHELATION THERAPY Study Sponsored by the National Institutes of Health Chelation (key-LAY-shun)Therapy is being studied as a potential treatment for coronary heart disease in people who have had a previous heart attack. If you participate in this study, you will receive 28 months of treatment and up to 32 months of follow-up. You will not be charged for participating in this study and will receive vitamin and mineral supplements.

Inclusions:		We are seeking volunteers 50 years or older who have survived a heart attack.

Exclusions:		You must not have smoked for the past 3 months and not have had chelation therapy for at least the last 5 years.

Clinical Trial Site:		Johns Hopkins Bayview Medical Center 4940 Eastern Ave Bldg B room 420 Baltimore, MD 21224

Compensation for Participating?		No

Start Date:		January 2004

Anticipated End Date:		January 2008

	Maps & Directions \| Privacy Policy \| For Hopkins Employees \| Media Inquiries
	© 2008 Johns Hopkins Medicine, All Rights Reserved.